Simcere Pharmaceutical Group Future Growth
Future criteria checks 4/6
Simcere Pharmaceutical Group is forecast to grow earnings and revenue by 23.7% and 13.7% per annum respectively. EPS is expected to grow by 23.5% per annum. Return on equity is forecast to be 15.8% in 3 years.
Key information
23.8%
Earnings growth rate
23.5%
EPS growth rate
Pharmaceuticals earnings growth | 10.7% |
Revenue growth rate | 13.7% |
Future return on equity | 15.8% |
Analyst coverage | Good |
Last updated | 02 Jul 2024 |
Recent future growth updates
Recent updates
Why Simcere Pharmaceutical Group's (HKG:2096) Shaky Earnings Are Just The Beginning Of Its Problems
May 01Simcere Pharmaceutical Group Limited's (HKG:2096) Business And Shares Still Trailing The Market
Dec 29Need To Know: Analysts Just Made A Substantial Cut To Their Simcere Pharmaceutical Group Limited (HKG:2096) Estimates
Aug 28Are Investors Undervaluing Simcere Pharmaceutical Group Limited (HKG:2096) By 40%?
Jun 03Analysts Just Shaved Their Simcere Pharmaceutical Group Limited (HKG:2096) Forecasts Dramatically
Apr 06Estimating The Intrinsic Value Of Simcere Pharmaceutical Group Limited (HKG:2096)
Jan 10With EPS Growth And More, Simcere Pharmaceutical Group (HKG:2096) Makes An Interesting Case
Aug 16Simcere Pharmaceutical Group (HKG:2096) Has Announced A Dividend Of HK$0.18
Jun 27Simcere Pharmaceutical Group Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 27Should You Be Adding Simcere Pharmaceutical Group (HKG:2096) To Your Watchlist Today?
Mar 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 9,967 | 1,516 | 912 | 1,564 | 5 |
12/31/2025 | 8,720 | 1,306 | 756 | 1,152 | 6 |
12/31/2024 | 7,503 | 1,021 | 751 | 1,375 | 6 |
12/31/2023 | 6,608 | 715 | -829 | 151 | N/A |
9/30/2023 | 6,806 | 1,928 | -504 | 369 | N/A |
6/30/2023 | 6,999 | 3,144 | -178 | 588 | N/A |
3/31/2023 | 6,659 | 2,038 | 249 | 971 | N/A |
12/31/2022 | 6,324 | 931 | 676 | 1,354 | N/A |
9/30/2022 | 5,952 | 972 | 673 | 1,180 | N/A |
6/30/2022 | 5,579 | 1,013 | 671 | 1,006 | N/A |
3/31/2022 | 5,290 | 1,260 | 130 | 402 | N/A |
12/31/2021 | 5,000 | 1,507 | -411 | -202 | N/A |
9/30/2021 | 4,852 | 1,274 | -481 | -200 | N/A |
6/30/2021 | 4,703 | 1,042 | -551 | -198 | N/A |
3/31/2021 | 4,606 | 856 | -404 | -51 | N/A |
12/31/2020 | 4,509 | 670 | -256 | 97 | N/A |
9/30/2020 | 4,528 | 699 | -314 | -6 | N/A |
6/30/2020 | 4,548 | 728 | -371 | -109 | N/A |
3/31/2020 | 4,792 | 866 | -53 | 332 | N/A |
12/31/2019 | 5,037 | 1,004 | 265 | 773 | N/A |
12/31/2018 | 4,514 | 734 | 441 | 776 | N/A |
12/31/2017 | 3,868 | 350 | 647 | 939 | N/A |
9/30/2013 | 2,027 | 193 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2096's forecast earnings growth (23.7% per year) is above the savings rate (2.2%).
Earnings vs Market: 2096's earnings (23.7% per year) are forecast to grow faster than the Hong Kong market (11.3% per year).
High Growth Earnings: 2096's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2096's revenue (13.7% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 2096's revenue (13.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2096's Return on Equity is forecast to be low in 3 years time (15.8%).